{"version":"1.0","provider_name":"FGK Group","provider_url":"https:\/\/fgk-group.com\/de\/","author_name":"FGK_Group","author_url":"https:\/\/fgk-group.com\/de\/author\/fgk_group\/","title":"EpiEndo Pharmaceuticals - FGK Group","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"lofA0CW4dv\"><a href=\"https:\/\/fgk-group.com\/de\/fgk-cro\/ueber-uns\/referenzen\/epiendo-pharmaceuticals\/\">EpiEndo Pharmaceuticals<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/fgk-group.com\/de\/fgk-cro\/ueber-uns\/referenzen\/epiendo-pharmaceuticals\/embed\/#?secret=lofA0CW4dv\" width=\"600\" height=\"338\" title=\"&#8222;EpiEndo Pharmaceuticals&#8220; &#8211; FGK Group\" data-secret=\"lofA0CW4dv\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/fgk-group.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Kate Hanrott, EpiEndo Pharmaceuticals Director Clinical Operations and Sciences \u201eFGK hat zwei hochwertige Studien f\u00fcr uns durchgef\u00fchrt, daher fiel uns die Entscheidung leicht, auch unsere n\u00e4chste Studie an FGK zu vergeben. Die Zusammenarbeit mit allen Mitgliedern des FGK-Teams ist sehr angenehm. Sie legen gro\u00dfen Wert auf Qualit\u00e4t und scheuen keine M\u00fchen, um das Beste zu [&hellip;]","thumbnail_url":"https:\/\/fgk-group.com\/wp-content\/uploads\/2025\/08\/EpiEndoLogo_RGB_Positive-scaled.png","thumbnail_width":2560,"thumbnail_height":797}